Burcon to Host Virtual Investor Presentation on November 20, 2024 in Lieu of Fiscal 2025 Q2 Conference Call
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a plant-based protein technology company, announces a virtual investor presentation scheduled for November 20, 2024, at 5:00 p.m. Eastern time. The presentation will replace the previously announced Fiscal 2025 Q2 Conference Call. Management will discuss the company's capital-light business strategy, commercial production, customer demand, and provide a technology commercialization update and financial outlook. The event will include a Q&A session, and financial results for Fiscal 2025 Q2 will be released on November 14, 2024.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), un azienda di tecnologia proteica vegetale, annuncia una presentazione virtuale per gli investitori programmata per il 20 novembre 2024, alle 17:00 ora orientale. La presentazione sostituirà la precedente chiamata per la conferenza sul secondo trimestre fiscale 2025. La dirigenza discuterà della strategia aziendale a basso capitale, della produzione commerciale, della domanda dei clienti e fornirà un aggiornamento sulla commercializzazione della tecnologia e le prospettive finanziarie. L'evento includerà una sessione di domande e risposte e i risultati finanziari per il secondo trimestre fiscale 2025 saranno rilasciati il 14 novembre 2024.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), una empresa de tecnología de proteínas a base de plantas, anuncia una presentación virtual para inversores programada para el 20 de noviembre de 2024, a las 5:00 p.m. hora del este. La presentación reemplazará la llamada de conferencia previamente anunciada para el segundo trimestre fiscal 2025. La dirección discutirá la estrategia empresarial de bajo capital, la producción comercial, la demanda de los clientes y proporcionará una actualización sobre la comercialización de la tecnología y la perspectiva financiera. El evento incluirá una sesión de preguntas y respuestas, y los resultados financieros para el segundo trimestre fiscal 2025 se darán a conocer el 14 de noviembre de 2024.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), 식물 기반 단백질 기술 회사로, 2024년 11월 20일 동부 표준시 기준 오후 5시에 예정된 가상 투자자 발표를 알립니다. 이 발표는 이전에 발표된 2025 회계연도 2분기 컨퍼런스 콜을 대신합니다. 경영진은 자본이 적은 비즈니스 전략, 상업 생산, 고객 수요에 대해 논의하고 기술 상용화 업데이트 및 재무 전망을 제공합니다. 이 행사에는 질문 및 답변 세션이 포함되며, 2025 회계연도 2분기 재무 결과는 2024년 11월 14일에 발표될 예정입니다.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), une entreprise de technologie des protéines à base de plantes, annonce une présentation virtuelle pour les investisseurs prévue le 20 novembre 2024 à 17h00, heure de l'Est. Cette présentation remplacera la conférence téléphonique du deuxième trimestre de l'exercice 2025, précédemment annoncée. La direction discutera de la stratégie commerciale à faible capital, de la production commerciale, de la demande des clients et fournira une mise à jour sur la commercialisation de la technologie et les perspectives financières. L'événement comprendra une séance de questions-réponses, et les résultats financiers pour le deuxième trimestre de l'exercice 2025 seront publiés le 14 novembre 2024.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), ein Unternehmen für pflanzenbasierte Protein-Technologie, gibt eine virtuelle Investorenpräsentation bekannt, die für den 20. November 2024 um 17:00 Uhr Eastern Time angesetzt ist. Die Präsentation wird den zuvor angekündigten Conference Call für das zweite Quartal des Geschäftsjahres 2025 ersetzen. Das Management wird die kapitalleichte Geschäftsstrategie, die kommerzielle Produktion, die Kundennachfrage diskutieren und ein Update zur Technologisierung sowie den finanziellen Ausblick geben. Die Veranstaltung wird eine Frage- und Antwortsession beinhalten, und die finanziellen Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 werden am 14. November 2024 veröffentlicht.
- Strong customer demand reported for commercial production
- Implementation of capital-light business strategy
- None.
Technology commercialization update to be released in conjunction with Presentation
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold a virtual investor presentation on Wednesday, November 20, 2024 at 5:00 p.m. Eastern time.
This virtual event will feature a presentation from Burcon management and a moderated Q&A session. The topics covered will include:
- Corporate overview of our capital-light business strategy
- Commercial production and strong customer demand
- Technology commercialization update
- Financial outlook
Attendees can expect to gain valuable insights into the Company's business strategy and receive an update on its most recent developments.
"We've built a strong foundation for Burcon's growth and are ready to take the next steps in our evolution," said Kip Underwood, Burcon's chief executive officer. "We're eager to share our recent developments and our plan for the future."
A live Q&A session will follow the formal presentation. Attendees wishing to have a question addressed at the event can submit them in advance to plam@burcon.ca.
Event Details
A link to the webcast of the conference call is available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future playback.
Investors interested in participating in the live call can dial in using the details below:
Date: Wednesday November 20, 2024
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in (North America): 1-800-717-1738
Dial-in (toll/international): 1-646-307-1865
Conference ID: 64804
Fiscal 2025 Second Quarter Results and Conference Call
Burcon will host the virtual investor presentation in lieu of its previously announced Fiscal 2025 Second Quarter Conference Call originally scheduled for Wednesday November 13, 2024, at 5:00pm Eastern time.
The Company's financial results for Fiscal 2025 second quarter will be issued in a press release and filed on SEDAR+ at the close of market on Thursday November 14, 2024.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229735
FAQ
When is Burcon NutraScience (BRCNF) hosting its virtual investor presentation?
What topics will Burcon NutraScience (BRCNF) cover in its November 2024 investor presentation?
When will Burcon NutraScience (BRCNF) release its Fiscal 2025 Q2 financial results?
